Jupiter Neurosciences, Inc. (JUNS) Stock Statistics & Valuation Metrics

Jupiter Neurosciences, Inc. has a market cap or net worth of $13.51M. The enterprise value is $15.04M.

Jupiter Neurosciences, Inc. has 36,281,254 shares outstanding. The number of shares has decreased by -2.65% in one year.

Jupiter Neurosciences, Inc.’s return on equity (ROE) is 4.72 and return on invested capital (ROIC) is -255.45%.

The current PE Ratio of Jupiter Neurosciences, Inc. is ―. Jupiter Neurosciences, Inc.’s PEG ratio is -0.02.

In the last 12 months, Jupiter Neurosciences, Inc. had revenue of 21.80K and earned -8.64M in profits. Earnings per share was -0.25.

In the last 12 months, operating cash flow was -5.41M and capital expenditures 0.00, giving a free cash flow of -5.41M billion.

Jupiter Neurosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Jupiter Neurosciences, Inc. upcoming earnings date is ―, ―.

Jupiter Neurosciences, Inc. as a current ratio of 0.65, with Debt / Equity ratio of -290.38%

In the past 12 months, Jupiter Neurosciences, Inc. has paid 0.00 in taxes.

Jupiter Neurosciences, Inc. EV to EBITDA ratio is -4.14, with an EV/FCF ratio of -6.81.

Jupiter Neurosciences, Inc. has $3.79M in cash and marketable securities with $5.32M in debt, giving a net cash position of -$1.53M billion.

Gross margin is 80.59%, with operating margin of -40873.19%, and net profit margin of -39662.77%.

The average price target for Jupiter Neurosciences, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is Moderate Buy